127 related articles for article (PubMed ID: 2793377)
21. Paclitaxel plus gallium nitrate and filgrastim in patients with refractory malignancies: a phase I trial.
Sandler A; Fox S; Meyers T; Christou A; Weber G; Gonin R; Loehrer PJ; Einhorn LH; Dreicer R
Am J Clin Oncol; 1998 Apr; 21(2):180-4. PubMed ID: 9537208
[TBL] [Abstract][Full Text] [Related]
22. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Malfetano JH; Blessing JA; Homesley HD; Hanjani P
Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
[TBL] [Abstract][Full Text] [Related]
23. Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
Kornek GV; Haider K; Kwasny W; Hejna M; Raderer M; Meghdadi S; Burger D; Schneeweiss B; Depisch D; Scheithauer W
Br J Cancer; 1996 Nov; 74(10):1668-73. PubMed ID: 8932353
[TBL] [Abstract][Full Text] [Related]
24. 5-Fluorouracil rechallenge by protracted infusion in refractory breast cancer.
Jabboury K; Holmes FA; Hortobagyi G
Cancer; 1989 Aug; 64(4):793-7. PubMed ID: 2743272
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of gallium nitrate in patients with advanced malignant melanoma.
Casper ES; Stanton GF; Sordillo PP; Parente R; Michaelson RA; Vinceguerra V
Cancer Treat Rep; 1985 Sep; 69(9):1019-20. PubMed ID: 4028034
[TBL] [Abstract][Full Text] [Related]
26. Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study.
Crawford ED; Saiers JH; Baker LH; Costanzi JH; Bukowski RM
Urology; 1991 Oct; 38(4):355-7. PubMed ID: 1755146
[TBL] [Abstract][Full Text] [Related]
27. Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial.
Keller J; Bartolucci A; Carpenter JT; Feagler J
Cancer Treat Rep; 1986 Oct; 70(10):1221-3. PubMed ID: 3530448
[TBL] [Abstract][Full Text] [Related]
28. Treating cancer-related hypercalcemia with gallium nitrate.
Leyland-Jones B
J Support Oncol; 2004; 2(6):509-16. PubMed ID: 15605917
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.
Theriault RL; Walters RS; Holmes FA; Esparza-Guerra L; Kowal C; Hortobagyi GN
Cancer Chemother Pharmacol; 1996; 38(3):289-91. PubMed ID: 8646805
[TBL] [Abstract][Full Text] [Related]
30. Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer.
Zambelli A; Robustelli della Cuna FS; Ponchio L; Ucci G; Da Prada GA; Robustelli della Cuna G
Breast Cancer Res Treat; 2000 Jun; 61(3):241-7. PubMed ID: 10966000
[TBL] [Abstract][Full Text] [Related]
31. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
Abigerges D; Chabot GG; Armand JP; Hérait P; Gouyette A; Gandia D
J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
33. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM
Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208
[TBL] [Abstract][Full Text] [Related]
34. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage.
Arumugam GP; Sundravel S; Shanthi P; Sachdanandam P
J Bone Miner Metab; 2006; 24(3):243-7. PubMed ID: 16622738
[TBL] [Abstract][Full Text] [Related]
36. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
Blumenreich MS; Woodcock TM; Gentile PS; Barnes GR; Jose B; Sherrill EJ; Richman SP; Epremian BE; Kubota TT; Allegra JC
J Clin Oncol; 1987 Nov; 5(11):1725-30. PubMed ID: 2824706
[TBL] [Abstract][Full Text] [Related]
37. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer.
Miles DW; Smith IE; Coleman RE; Calvert AH; Lind MJ
Eur J Cancer; 2001 Jul; 37(11):1366-71. PubMed ID: 11435066
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma.
Pazdur R; Diaz-Canton E; Ballard WP; Bradof JE; Graham S; Arbuck SG; Abbruzzese JL; Winn R
J Clin Oncol; 1997 Aug; 15(8):2905-9. PubMed ID: 9256134
[TBL] [Abstract][Full Text] [Related]
40. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
